Registry on extracorporeal multiple organ support with the advanced organ support (ADVOS) system
暂无分享,去创建一个
A. Kribben | J. Lutz | S. Kluge | Aritz Perez Ruiz de Garibay | B. Tyczynski | V. Fuhrmann | J. Weinmann-Menke | D. Jarczak | A. Faltlhauser | Julia Weinmann-Menke
[1] R. Schmid,et al. Extracorporeal multiorgan support including CO2-removal with the ADVanced Organ Support (ADVOS) system for COVID-19: A case report , 2020, The International journal of artificial organs.
[2] J. Kellum,et al. Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure , 2020, Annals of Intensive Care.
[3] M. Bauer,et al. Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced Organ Support system in critically ill patients with liver failure—A retrospective analysis , 2020, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[4] W. Huber,et al. Options in extracorporeal support of multiple organ failure , 2020, Medizinische Klinik - Intensivmedizin und Notfallmedizin.
[5] P. Kiekkas,et al. Extracorporeal Life Support: The Next Step in Moderate to Severe ARDS—A Review and Meta-Analysis of the Literature , 2019, BioMed research international.
[6] J. Kellum,et al. Respiratory and metabolic acidosis correction with the ADVanced Organ Support system , 2019, Intensive Care Medicine Experimental.
[7] C. Ronco. Introduction , 2019, Blood Purification.
[8] J. Vincent. Introduction to Extracorporeal Multiple Organ Support , 2018, Blood Purification.
[9] Arthur S Slutsky,et al. Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk , 2018, Intensive Care Medicine.
[10] J. Vincent,et al. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP) , 2018, Intensive Care Medicine.
[11] Amy P. Abernethy,et al. Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality , 2017, Clinical pharmacology and therapeutics.
[12] D. Brodie,et al. Extracorporeal Organ Support: From Technological Tool to Clinical Strategy Supporting Severe Organ Failure. , 2017, JAMA.
[13] Aritz Perez Ruiz de Garibay,et al. Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia , 2017, Intensive Care Medicine Experimental.
[14] M. Bailey,et al. Effects of Hypercapnia and Hypercapnic Acidosis on Hospital Mortality in Mechanically Ventilated Patients* , 2017, Critical care medicine.
[15] C. Zauner,et al. Renal replacement therapy in critically ill liver cirrhotic patients—outcome and clinical implications , 2017, Liver international : official journal of the International Association for the Study of the Liver.
[16] R. Schmid,et al. First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis , 2017, BMC Gastroenterology.
[17] C. Zauner,et al. Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit , 2016, Annals of Intensive Care.
[18] Rinaldo Bellomo,et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study , 2015, Intensive Care Medicine.
[19] William M. Lee,et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[20] D. Ilic,et al. Extracorporeal membrane oxygenation for critically ill adults. , 2015, The Cochrane database of systematic reviews.
[21] John A. Kellum,et al. Increased serum bicarbonate in critically ill patients: a retrospective analysis , 2015, Intensive Care Medicine.
[22] T. Schuster,et al. Evaluation of the Hepa Wash® treatment in pigs with acute liver failure , 2013, BMC Gastroenterology.
[23] Chris Wakefield,et al. Cross-validation of a Sequential Organ Failure Assessment score-based model to predict mortality in patients with cancer admitted to the intensive care unit. , 2012, Journal of critical care.
[24] C. Zauner,et al. Jaundice increases the rate of complications and one‐year mortality in patients with hypoxic hepatitis , 2012, Hepatology.
[25] Angelito A. Bernardo,et al. Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia. , 2012, Kidney international.
[26] S. Jaber,et al. Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. a prospective, multiple-center study , 2011, Critical care.
[27] James Paparello,et al. Thrombocytopenia associated with dialysis treatments , 2011, Hemodialysis international. International Symposium on Home Hemodialysis.
[28] J. Vincent,et al. Is worsening multiple organ failure the cause of death in patients with severe sepsis?* , 2011, Critical care medicine.
[29] S. Bratton,et al. Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality* , 2011, Critical care medicine.
[30] John A Kellum,et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.
[31] J. Vincent,et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.
[32] C. Sprung,et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. , 1998, Critical care medicine.
[33] J. Vincent,et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.
[34] C. Ronco,et al. From Continuous Renal Replacement Therapies to Multiple Organ Support Therapy. , 2018, Contributions to nephrology.